361
Views
19
CrossRef citations to date
0
Altmetric
Reviews

Targeting tyrosine-kinases in ovarian cancer

, MD, , MD, , MD & , MD PhD
Pages 1265-1279 | Published online: 02 Jul 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Caijin Zhou, Linxia Chen, Rihong Chen, Feipeng Xu, Zhe Huang, Renwei Huang, Weiwei Wang & Qingwen Xu. (2022) miR-4486 enhances cisplatin sensitivity of gastric cancer cells by restraining the JAK3/STAT3 signalling pathway. Journal of Chemotherapy 34:1, pages 35-44.
Read now
Ciro Pinelli, Matteo Morotti, Jvan Casarin, Roberto Tozzi, Fabio Ghezzi, Vasileios K. Mavroeidis, Moiad Alazzam & Hooman Soleymani majd. (2021) Interval Debulking Surgery for Advanced Ovarian Cancer in Elderly Patients (≥70 y): Does the Age Matter?. Journal of Investigative Surgery 34:9, pages 1023-1030.
Read now
Ciro Pinelli, Matteo Morotti, Jvan Casarin, Roberto Tozzi, Moiad Alazzam, Vasileios K. Mavroeidis & Hooman Soleymani majd. (2021) The Feasibility of Cardiophrenic Lymphnode Assessment and Removal in Patients Requiring Diaphragmatic Resection During Interval Debulking Surgery for Ovarian Cancer. Journal of Investigative Surgery 34:7, pages 756-762.
Read now
Giulio Evangelisti, Fabio Barra, Melita Moioli, Paolo Sala, Sara Stigliani, Claudio Gustavino, Sergio Costantini & Simone Ferrero. (2020) Prexasertib: an investigational checkpoint kinase inhibitor for the treatment of high-grade serous ovarian cancer. Expert Opinion on Investigational Drugs 29:8, pages 779-792.
Read now
Ioannis Ntanasis-Stathopoulos, George Fotopoulos, Ioannis-Georgios Tzanninis & Elias A. Kotteas. (2016) The Emerging Role of Tyrosine Kinase Inhibitors in Ovarian Cancer Treatment: A Systematic Review. Cancer Investigation 34:7, pages 313-339.
Read now

Articles from other publishers (14)

Heba M. Mansour, Ahmed F. Mohamed, Mahmoud M. Khattab & Aiman S. El-Khatib. (2023) Pazopanib ameliorates rotenone-induced Parkinsonism in rats by suppressing multiple regulated cell death mechanisms. Food and Chemical Toxicology 181, pages 114069.
Crossref
Yan Wang, Yan Cai & Qi-Ming Wang. (2023) A Systematic Review and Meta-Analysis: Safety and Efficacy of Cediranib in the Treatment of Cancer Patients. Journal of Clinical Pharmacy and Therapeutics 2023, pages 1-12.
Crossref
Roberto Tozzi, Jvan Casarin, Ahmet Baysal, Ciro Pinelli, Luka Matak, Nahid Ghanbarzadeh, Moiad Alazzam, Riccardo Garruto-Campanile, Hooman Soleymani Majd, Yakup Kilic & Matteo Morotti. (2019) Morbidity of multiple bowel resection compared to single bowel resection after debulking surgery for ovarian cancer. European Journal of Obstetrics & Gynecology and Reproductive Biology 240, pages 215-219.
Crossref
Guang Song, Li Chen, Bai Zhang, Qifeng Song, Yu Yu, Cedric Moore, Tian-Li Wang, Ie-Ming Shih, Hui Zhang, Daniel W. Chan, Zhen Zhang & Heng Zhu. (2019) Proteome-wide Tyrosine Phosphorylation Analysis Reveals Dysregulated Signaling Pathways in Ovarian Tumors. Molecular & Cellular Proteomics 18:3, pages 448-460.
Crossref
Matteo Morotti, Prashanth Hari Dass, Adrian L. Harris & Simon Lord. (2017) Pharmacodynamic and Pharmacokinetic Markers For Anti-angiogenic Cancer Therapy: Implications for Dosing and Selection of Patients. European Journal of Drug Metabolism and Pharmacokinetics 43:2, pages 137-153.
Crossref
Wai-Kin So, Jung-Chien Cheng, Yingtao Liu, Congjian Xu, Jianfang Zhao, Vincent T. W. Chang & Peter C. K. Leung. (2016) Sprouty4 mediates amphiregulin-induced down-regulation of E-cadherin and cell invasion in human ovarian cancer cells. Tumor Biology 37:7, pages 9197-9207.
Crossref
C. Marchetti, I. Palaia, F. De Felice, A. Musella, C. Donfracesco, L. Vertechy, A. Romito, I. Piacenti, D. Musio, L. Muzii, V. Tombolini & P. Benedetti Panici. (2016) Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patients. Cancer Treatment Reviews 42, pages 41-46.
Crossref
Hongyi Liu, Peng Li, Bing Li, Peng Sun, Jiajin Zhang, Baishi Wang & Baoqing Jia. (2014) RKIP promotes cisplatin-induced gastric cancer cell death through NF-κB/Snail pathway. Tumor Biology 36:3, pages 1445-1453.
Crossref
Kazuhide Sato, Hirofumi Hanaoka, Rira Watanabe, Takahito Nakajima, Peter L. Choyke & Hisataka Kobayashi. (2015) Near Infrared Photoimmunotherapy in the Treatment of Disseminated Peritoneal Ovarian Cancer. Molecular Cancer Therapeutics 14:1, pages 141-150.
Crossref
Ben Davidson & Claes G Tropé. (2014) Ovarian Cancer: Diagnostic, Biological and Prognostic Aspects. Women's Health 10:5, pages 519-533.
Crossref
Ben Davidson, Claes G. Trope & Reuven Reich. (2014) The Role of the Tumor Stroma in Ovarian Cancer. Frontiers in Oncology 4.
Crossref
Xavier Matias-Guiu & Ben Davidson. (2014) Prognostic biomarkers in endometrial and ovarian carcinoma. Virchows Archiv 464:3, pages 315-331.
Crossref
Weiguo Cao, Weiping Yang, Rong Fan, Hao Li, Jinsong Jiang, Mei Geng, Yening Jin & Yunlin Wu. (2013) miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway. Tumor Biology 35:2, pages 1287-1295.
Crossref
Ling-jie Fu & Bing Wang. (2013) Investigation of the hub genes and related mechanism in ovarian cancer via bioinformatics analysis. Journal of Ovarian Research 6:1, pages 92.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.